NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.530
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT - Market closed
NEXGEL Revenue
In the year 2024, NEXGEL had annual revenue of $8.69M with 112.47% growth. NEXGEL had revenue of $3.04M in the quarter ending December 31, 2024, with 181.05% growth.
Revenue (ttm)
$8.69M
Revenue Growth
+112.47%
P/S Ratio
1.90
Revenue / Employee
$457,263
Employees
19
Market Cap
19.36M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
NXGL News
- 5 weeks ago - NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th - GlobeNewsWire
- 2 months ago - NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025 - GlobeNewsWire
- 4 months ago - NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer - GlobeNewsWire
- 5 months ago - NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially - GlobeNewsWire
- 6 months ago - NEXGEL Announces $2,000,000 Registered Direct Offering - GlobeNewsWire